Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Human iPSC line was generated from patient-specific adipose tissue-derived mesenchymal multipotent stromal cells carrying two mutations in plakophilin-2 (PKP2) gene using non-integrative reprogramming method. Reprogramming factors OCT4, KLF4, SOX2, CMYC were delivered using Sendai viruses. Pluripotency was confirmed in vitro using immunofluorescence and RT-PCR analysis and in vivo by teratoma assay. The reported iPSC line could be useful tool for in vitro modeling of arrhythmogenic right ventricular cardiomyopathy.
Pubmed ID: 29034900
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets POU5F1
View all literature mentionsThis monoclonal targets SSEA-4
View all literature mentionsThis monoclonal targets HSP90B1
View all literature mentionsThis monoclonal targets TRA-1-81 clone TRA-1-81
View all literature mentionsThis monoclonal targets NEW NANOG clone 7F7.1
View all literature mentionsThis unknown targets IgG (H+L)
View all literature mentions